|
|
|
Volumn 306, Issue 5705, 2004, Pages 2170-
|
|
Halt of celebrex study threatens drug's future, other trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
NAPROXEN;
ROFECOXIB;
VALDECOXIB;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
CARDIOVASCULAR DISEASE;
COLON POLYP;
DOSE RESPONSE;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HEART INFARCTION;
HUMAN;
NOTE;
PRIORITY JOURNAL;
STROKE;
ALZHEIMER DISEASE;
ARTICLE;
CEREBROVASCULAR ACCIDENT;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG INDUSTRY;
HEALTH CARE ORGANIZATION;
UNITED STATES;
ALZHEIMER DISEASE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIALS;
COLONIC POLYPS;
CYCLOOXYGENASE INHIBITORS;
DRUG INDUSTRY;
HUMANS;
MYOCARDIAL INFARCTION;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PYRAZOLES;
SULFONAMIDES;
UNITED STATES;
|
|
EID: 11144256197
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (29)
|
|
References (0)
|